Morgan Stanley’s Moleculin Biotech MBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$280 Hold
926
﹤0.01% 7526
2025
Q1
$901 Buy
926
+500
+117% +$487 ﹤0.01% 7294
2024
Q4
$724 Sell
426
-23
-5% -$39 ﹤0.01% 7309
2024
Q3
$1.28K Buy
449
+23
+5% +$65 ﹤0.01% 7193
2024
Q2
$1.5K Buy
426
+3
+0.7% +$11 ﹤0.01% 7102
2024
Q1
$2.5K Sell
423
-422
-50% -$2.49K ﹤0.01% 7030
2023
Q4
$10.9K Buy
845
+423
+100% +$5.44K ﹤0.01% 6819
2023
Q3
$2.71K Hold
422
﹤0.01% 7062
2023
Q2
$3.67K Hold
422
﹤0.01% 7050
2023
Q1
$6.08K Sell
422
-1
-0.2% -$14 ﹤0.01% 7011
2022
Q4
$6.72K Buy
423
+22
+5% +$349 ﹤0.01% 7071
2022
Q3
$6K Buy
401
+1
+0.3% +$15 ﹤0.01% 7209
2022
Q2
$9K Sell
400
-2
-0.5% -$45 ﹤0.01% 7246
2022
Q1
$11K Buy
402
+2
+0.5% +$55 ﹤0.01% 7376
2021
Q4
$11K Hold
400
﹤0.01% 7444
2021
Q3
$18K Sell
400
-248
-38% -$11.2K ﹤0.01% 7137
2021
Q2
$36K Hold
648
﹤0.01% 6799
2021
Q1
$39K Buy
+648
New +$39K ﹤0.01% 6464
2020
Q1
Sell
-388
Closed -$32K 6644
2019
Q4
$32K Sell
388
-2
-0.5% -$165 ﹤0.01% 5979
2019
Q3
$39K Buy
390
+41
+12% +$4.1K ﹤0.01% 5815
2019
Q2
$39K Buy
349
+210
+151% +$23.5K ﹤0.01% 5708
2019
Q1
$10K Hold
139
﹤0.01% 6183
2018
Q4
$13K Buy
139
+1
+0.7% +$94 ﹤0.01% 6114
2018
Q3
$20K Sell
138
-1
-0.7% -$145 ﹤0.01% 6135
2018
Q2
$22K Buy
139
+5
+4% +$791 ﹤0.01% 6127
2018
Q1
$22K Sell
134
-5
-4% -$821 ﹤0.01% 6107
2017
Q4
$23K Sell
139
-7
-5% -$1.16K ﹤0.01% 6043
2017
Q3
$32K Buy
146
+21
+17% +$4.6K ﹤0.01% 5906
2017
Q2
$21K Buy
125
+5
+4% +$840 ﹤0.01% 6068
2017
Q1
$13K Buy
120
+112
+1,400% +$12.1K ﹤0.01% 6182
2016
Q4
$2K Hold
8
﹤0.01% 6383
2016
Q3
$4K Sell
8
-5
-38% -$2.5K ﹤0.01% 6275
2016
Q2
$8K Buy
+13
New +$8K ﹤0.01% 6107